Desktop Site
|
23 Apr 24 | 16:00
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
*
Notices
|
S&P
BSE SENSEX
73,738.45
+89.83
+0.12 %
Corporate Announcement
Security Code
524404
Company
MARKSANS PHARMA LTD.
Exchange Disseminated Time
Board to consider Dividend |
5/23/2020 2:05:13 PM
Marksans Pharma Ltd has informed BSE that the Meeting of the Board of Directors of the Company will be held on June 02, 2020, to consider and approve the Annual Audited Financial Results of the Company (both Standalone and Consolidated) for the Financial Year ended March 31, 2020. The Board of Directors will also consider recommendation of dividend, if any, for
the Financial Year 2019-20.
Further as per the Insider Trading Code of the Company, the Trading Window for dealing in Company’s shares has been closed for the Company’s insiders from April 01, 2020 and will remain closed till Forty-Eight hours after the announcement of the Financial Results on June 02, 2020.
<< Back
Recently Viewed